CD36 and type 2 diabetes mellitus: For instance, patients with type II diabetes mellitus exhibited the overexpression of various pro-inflammatory M1 polarisation markers [CD16, interleukin-6 (IL-6), iNOS, tumor necrosis factor-α (TNF-α), and CD36] in their PBMCs compared to healthy subjects [50].